BRCA1 and ovarian cancer: In this work, we set the objectives to evaluate the prevalence of pathogenic BRCA1/2 germline and somatic mutations patients with ovarian cancer in population of Portsmouth, UK, and to evaluate the usefulness and serviceability of tBRCA1/2 mutations analysis.